Skip to main content
Be The Investor
AAVE

Aave

AAVE#49
$134.99
-0.43% (24H)
Market Cap
$2.08B
+0.35%
24H Volume
$176.29M
Circ. Supply
-
Total Supply
16.00M AAVE
Max Supply
16.00M AAVE
FDV
$2.16B
Dominance
-
All-Time High
-

Aave (AAVE) News

The latest Aave (AAVE) news in one feed: protocol upgrades, partnership announcements, regulatory updates and price analysis, curated by BTI.

Aave’s Institutional Lending Case Is Stronger Than the AAVE Token Case

Aave Horizon lets qualified institutions borrow stablecoins against tokenized assets, matching a growing collateral-use case. That adoption does not automatically create value for AAVE holders, making governance and buybacks the key link.

Citi’s Aave Thesis Highlights a Gap Between Protocol Use and AAVE Value

Citi Research sees Aave as potential infrastructure for tokenized collateral, but institutional use would not automatically create demand for the AAVE token. The investment case depends on borrowing activity, protocol fees and governance-directed buybacks.

Aave's Proposed USAT Gateway Adds Permission Risk to the Return Trip

Aave contributors proposed a permissioned Avalanche gateway between waUSAT and GHO. Users could transfer GHO freely, but recovering the deposited receipt token would require continuing approval and sufficient liquidity.

Aave V4 Would Put DAO Capital First in Line to Absorb Lending Losses

Aave V4 proposes using DAO-controlled funds as an early loss-absorption layer before losses reach users. The design could strengthen confidence, but it also exposes governance capital directly to bad debt and liquidation failures.

Aave’s 6.1% Stablecoin Yield Masks a Withdrawal Buffer of Just $4.4 Million

Aave’s USDT0 pool on Monad offered a 6.1% APR while only about $4.4 million of $55.9 million supplied remained unborrowed. The yield looks attractive, but liquidity availability matters more than headline APR for large exits.

Market data is provided for informational purposes only. Not investment advice. Past performance is not indicative of future results.